Global Travel Vaccines Market
Pharmaceuticals

Emerging Trends Redefining the Transcatheter Valve Repair System Market Landscape: Takeda’s QDENGA Approval Marks A Milestone In Travel Vaccine Innovation

Discover trends, market shifts, and competitive outlooks for the travel vaccines industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The Travel Vaccines Market Growth Evolved From 2024 To 2025, And What’s Ahead?

In recent years, the market size for travel vaccines has seen a robust growth. It is projected to expand from $4.73 billion in 2024 to $5.14 billion in 2025, marking a compound annual growth rate (CAGR) of 8.6%. This growth during the historical period can be linked to factors such as more people traveling internationally, government health initiatives for travelers, the spread of diseases due to globalization, rising awareness among travelers, and the growth of the travel and tourism industry.

The market size of travel vaccines is anticipated to experience substantial growth in the forthcoming years, escalating to $7.49 billion in 2029 with a compound annual growth rate (CAGR) of 9.9%. The predicted growth during the forecast period can be ascribed to factors such as an increased rate of business travel, the emergence of infectious disease risks, regulatory mandates and entry prerequisites by the government, a surge in demand for unique travel destinations, and partnerships between government entities and pharmaceutical firms. The forecast period is expected to witness trends like customized vaccination approaches, market extension into areas previously not affected, the embracement of digital health technologies, regulatory backing, expedited approvals, and innovative advancements.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

What Are the Core Market Drivers Propelling Growth in the Travel Vaccines Industry?

The growth of the travel vaccine market is anticipated to be driven by the surge in travel and tourism. Travel and tourism encompass the movement of individuals and objects, facilitated by various modes of transportation such as trains, ships, aircraft, and other vehicles, across different distant geographic locations. Travel vaccines offer protection to tourists and travelers, ensuring their health and safety during their overseas journeys. For example, the United Nations World Tourism Organization (UNWTO), an intergovernmental tourism promotion agency based in Spain, reported in January 2023 that over 900 million tourists traveled internationally in 2022, a figure twice that of 2021 and 63% higher than before the pandemic. Consequently, the uptick in travel and tourism is fueling the expansion of the travel vaccine market.

How Is the Travel Vaccines Market Segmented?

The travel vaccines market covered in this report is segmented –

1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,

2) By Composition: Mono Vaccines, Combination Vaccines

3) By Booking Channel: Online Booking, In-Person Booking

4) By Application: Domestic Travel, Outbound Travel

Subsegments:

1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines

2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)

3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines

4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine

5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines

6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine

7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)

8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine

9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=11918&type=smp

Which Regions Are Driving the Next Phase of the Travel Vaccines Market Growth?

North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Travel Vaccines Industry?

The travel vaccine market is seeing a surge in product innovation, with key players making strides in developing new vaccines to maintain market domination. For instance, Takeda Pharmaceutical Company Limited, a pharmaceutical firm based in Japan, obtained approval in August 2022, for its innovative QDENGA (Dengue Tetravalent Vaccine) (TAK-003) from the Indonesia National Agency for Drug and Food Control. This vaccine aims to prevent dengue fever caused by any serotype in individuals aged 6 to 45, offering comprehensive protection against dengue disease and hospitalization, with efficacy lasting three years post-immunization, irrespective of previous exposure to the disease.

View the full report here:

https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

How Is the Travel Vaccines Market Defined and What Are Its Core Parameters?

Travel vaccines are vaccines to protect against diseases that are either indigenous to the country of origin or the country of destination. They function to safeguard travelers and stop the spread of disease both within and between nations.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11918

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model